CY1111404T1 - Αντιβιοτικες συνθεσεις οι οποιες πeριεχουν παραγωγα μοξιφλοξασινης για θεραπεια του οφθαλμου - Google Patents
Αντιβιοτικες συνθεσεις οι οποιες πeριεχουν παραγωγα μοξιφλοξασινης για θεραπεια του οφθαλμουInfo
- Publication number
- CY1111404T1 CY1111404T1 CY20111100409T CY111100409T CY1111404T1 CY 1111404 T1 CY1111404 T1 CY 1111404T1 CY 20111100409 T CY20111100409 T CY 20111100409T CY 111100409 T CY111100409 T CY 111100409T CY 1111404 T1 CY1111404 T1 CY 1111404T1
- Authority
- CY
- Cyprus
- Prior art keywords
- compositions containing
- derivatives
- compositions
- antibiotic compositions
- eye therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10250498P | 1998-09-30 | 1998-09-30 | |
| US10250698P | 1998-09-30 | 1998-09-30 | |
| EP03020587A EP1384478B1 (en) | 1998-09-30 | 1999-09-29 | Antibiotic compositions containing moxifloxacin for treatment of the eye |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1111404T1 true CY1111404T1 (el) | 2015-08-05 |
Family
ID=26799441
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20111100409T CY1111404T1 (el) | 1998-09-30 | 2011-04-21 | Αντιβιοτικες συνθεσεις οι οποιες πeριεχουν παραγωγα μοξιφλοξασινης για θεραπεια του οφθαλμου |
| CY20141100819T CY1115759T1 (el) | 1998-09-30 | 2014-10-09 | Αντιβιοτικες συνθεσεις για θεραπεια του οφθαλμου |
| CY20151100023T CY1115916T1 (el) | 1998-09-30 | 2015-01-09 | Αντιβιοτικες συνθεσεις για θεραπεια του αυτιου |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20141100819T CY1115759T1 (el) | 1998-09-30 | 2014-10-09 | Αντιβιοτικες συνθεσεις για θεραπεια του οφθαλμου |
| CY20151100023T CY1115916T1 (el) | 1998-09-30 | 2015-01-09 | Αντιβιοτικες συνθεσεις για θεραπεια του αυτιου |
Country Status (18)
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6509327B1 (en) * | 1998-09-30 | 2003-01-21 | Alcon Manufacturing, Ltd. | Compositions and methods for treating otic, ophthalmic and nasal infections |
| AR020661A1 (es) | 1998-09-30 | 2002-05-22 | Alcon Lab Inc | Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento |
| US6395746B1 (en) | 1998-09-30 | 2002-05-28 | Alcon Manufacturing, Ltd. | Methods of treating ophthalmic, otic and nasal infections and attendant inflammation |
| US6716830B2 (en) | 1998-09-30 | 2004-04-06 | Alcon, Inc. | Ophthalmic antibiotic compositions containing moxifloxacin |
| DE19937116A1 (de) | 1999-08-06 | 2001-02-08 | Bayer Ag | Moxifloxacin Kochsalzformulierung |
| DE19937115A1 (de) * | 1999-08-06 | 2001-02-08 | Bayer Ag | Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon |
| WO2001022936A1 (en) | 1999-09-24 | 2001-04-05 | Alcon Universal Ltd. | Topical suspension formulations containing ciprofloxacin and dexamethasone |
| DE19962470A1 (de) | 1999-12-22 | 2001-07-12 | Schulz Hans Herrmann | Verwendung von Chemotherapeutika |
| WO2001089495A2 (en) * | 2000-05-19 | 2001-11-29 | Alcon Laboratories, Inc. | Antibiotic compositions containing quinolone derivatives for treatment of the eye, ear and nose |
| US6462033B2 (en) | 2000-07-26 | 2002-10-08 | Alcon Universal Ltd. | Process for manufacturing compositions containing ciprofloxacin and hydrocortisone |
| JPWO2002040028A1 (ja) * | 2000-11-16 | 2004-03-18 | わかもと製薬株式会社 | 抗菌ゲル化点眼剤 |
| AU2002228660A1 (en) | 2000-12-20 | 2002-07-01 | Alcon, Inc | Use of amidoamines to treat or prevent acanthamoeba and fungal infections |
| AU2002226926A1 (en) * | 2000-12-20 | 2002-07-01 | Alcon, Inc. | Antifungal compositions containing an antibiotic and one or more amidoamines |
| DK1429780T3 (da) | 2001-09-21 | 2006-02-13 | Fremgangsmåde til behandling af mellemoreinfektioner | |
| US7220431B2 (en) | 2002-11-27 | 2007-05-22 | Regents Of The University Of Minnesota | Methods and compositions for applying pharmacologic agents to the ear |
| NZ545472A (en) | 2003-09-10 | 2009-09-25 | Kyorin Seiyaku Kk | 7-(4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl)quinolonecarboxylic acid derivative |
| WO2006015545A1 (fr) * | 2004-08-11 | 2006-02-16 | Shenzhen Tys R & D Co., Ltd. | Capsule de gelatine de moxifloxacin et procede pour sa preparation |
| BRPI0514898A (pt) * | 2004-09-03 | 2008-06-24 | Piedmont Pharmaceuticals Llc | métodos para tratamento e prevenção transmembrana da otite média |
| DE102005055385A1 (de) * | 2004-12-09 | 2006-06-14 | Bayer Healthcare Ag | Arzneimittel zur hygienischen Applikation im Ohr |
| AU2005317228A1 (en) * | 2004-12-10 | 2006-06-22 | Alcon, Inc. | Compositions for treatment of ear infections |
| CN101317847B (zh) * | 2007-06-06 | 2010-10-13 | 深圳市瑞谷医药技术有限公司 | 一种眼用或耳鼻用药物组合物及其用途 |
| TWI495469B (zh) | 2008-06-09 | 2015-08-11 | Alcon Res Ltd | 含有氟喹諾酮抗生素藥物之經改良藥學組成物 |
| RU2570731C2 (ru) * | 2009-07-02 | 2015-12-10 | Алькон Рисерч, Лтд. | Композиции, включающие финафлоксации, и способы лечения офтальмологических, ушных или назальных инфекций |
| US20120289541A1 (en) * | 2010-01-07 | 2012-11-15 | Novartis Ag | Methods and compositions for applying moxifloxacin to the ear |
| MX2014006056A (es) | 2011-12-06 | 2014-08-08 | Alcon Res Ltd | Composicion de gel de celulosa con una mejor estabilidad de la viscosidad. |
| RU2472507C1 (ru) * | 2012-02-01 | 2013-01-20 | Закрытое акционерное общество "Брынцалов-А" | Водный состав на основе моксифлоксацина для парентерального введения |
| US9504691B2 (en) | 2012-12-06 | 2016-11-29 | Alcon Research, Ltd. | Finafloxacin suspension compositions |
| US20160279055A1 (en) | 2013-07-22 | 2016-09-29 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof |
| US20150164882A1 (en) | 2013-07-22 | 2015-06-18 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical compositions for intraocular administration and methods for fabricating thereof |
| CN104224802B (zh) * | 2014-09-19 | 2017-12-12 | 南京优科生物医药研究有限公司 | 一种盐酸莫西沙星滴耳剂及其制备方法 |
| RU2595837C2 (ru) * | 2014-09-29 | 2016-08-27 | Открытое Акционерное Общество "Татхимфармпрепараты" | Состав и способ получения глазных капель |
| US20180311225A1 (en) * | 2015-10-29 | 2018-11-01 | Teika Pharmaceutical Co., Ltd. | External preparation |
| WO2019193513A1 (en) * | 2018-04-03 | 2019-10-10 | Hyderabad Eye Research Foundation | Mucoadhesive drug delivery system for ocular administration of fluoroquinolone antibiotics |
| IT201900005280A1 (it) * | 2019-04-05 | 2020-10-05 | Ntc S R L | Composizione otologica |
| JP2023530254A (ja) * | 2020-06-10 | 2023-07-14 | オキュラー サイエンス，インク． | 手術後の眼科的ケアのための組成物および方法 |
| CN116270662A (zh) * | 2021-12-03 | 2023-06-23 | 苏州欧康维视生物科技有限公司 | 盐酸莫西沙星地塞米松磷酸钠滴眼液 |
| KR102656260B1 (ko) | 2022-10-14 | 2024-04-09 | 주식회사태준제약 | 목시플록사신을 포함하는 안과용 조성물 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223493A (en) | 1984-12-28 | 1993-06-29 | Alcon Laboratories, Inc. | Anti-inflammatory compounds for ophthalmic use |
| CA1325382C (en) * | 1988-01-27 | 1993-12-21 | Takahiro Ogawa | Locally administrable therapeutic composition for inflammatory disease |
| DE3906365A1 (de) * | 1988-07-15 | 1990-01-18 | Bayer Ag | 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe |
| AU4201189A (en) * | 1988-08-26 | 1990-03-23 | Alcon Laboratories, Inc. | Combination of quinolone antibiotics and steroids for topical ophthalmic use |
| JPH085779B2 (ja) * | 1989-09-22 | 1996-01-24 | 杏林製薬株式会社 | フレロキサシン点眼液 |
| JPH03109236A (ja) * | 1989-09-22 | 1991-05-09 | Hoya Corp | 半導体超微粒子分散ガラスの製造方法 |
| TW209865B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1992-01-10 | 1993-07-21 | Bayer Ag | |
| CA2132826C (en) | 1992-05-06 | 1999-01-05 | Masood Chowhan | Use of borate-polyol complexes in ophthalmic compositions |
| DE4424369A1 (de) * | 1994-07-11 | 1996-01-18 | Bayer Ag | Pyrido[3,2,1.i,j][3,1]benzoxazinderivate |
| JPH0892241A (ja) * | 1994-09-22 | 1996-04-09 | Ss Pharmaceut Co Ltd | ５−ヒドラジノキノロンカルボン酸誘導体及びこれを有効成分とする抗菌剤 |
| US5631287A (en) | 1994-12-22 | 1997-05-20 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
| WO1996039146A1 (en) * | 1995-06-06 | 1996-12-12 | Bayer Corporation | Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions |
| JP3290914B2 (ja) * | 1997-03-17 | 2002-06-10 | 参天製薬株式会社 | 眼組織におけるキノロン系抗菌剤の定量装置 |
| UA66812C2 (uk) * | 1997-09-25 | 2004-06-15 | Баєр Акцієнгезельшафт | Препаративна форма лікарського засобу із регульованим вивільненням активної речовини |
| EP1115371B1 (en) | 1998-09-23 | 2005-03-16 | Unilever N.V. | Oral care compositions |
| AR020661A1 (es) | 1998-09-30 | 2002-05-22 | Alcon Lab Inc | Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento |
| KR20010107754A (ko) * | 2000-05-26 | 2001-12-07 | 민경윤 | 경구투여용 속용정의 제조 방법 |
-
1999
- 1999-09-27 AR ARP990104866A patent/AR020661A1/es not_active Application Discontinuation
- 1999-09-29 ES ES99956504T patent/ES2207307T3/es not_active Expired - Lifetime
- 1999-09-29 AT AT03020587T patent/ATE501732T1/de active
- 1999-09-29 DK DK99956504T patent/DK1117401T3/da active
- 1999-09-29 JP JP2000571905A patent/JP2002525317A/ja active Pending
- 1999-09-29 PT PT03020587T patent/PT1384478E/pt unknown
- 1999-09-29 EP EP99956504A patent/EP1117401B1/en not_active Revoked
- 1999-09-29 CA CA002342211A patent/CA2342211C/en not_active Expired - Lifetime
- 1999-09-29 BR BRPI9914151-5A patent/BRPI9914151B1/pt not_active IP Right Cessation
- 1999-09-29 EP EP03020587A patent/EP1384478B1/en not_active Expired - Lifetime
- 1999-09-29 DK DK03020587.6T patent/DK1384478T3/da active
- 1999-09-29 PT PT99956504T patent/PT1117401E/pt unknown
- 1999-09-29 EP EP14176366.4A patent/EP2796138B1/en not_active Expired - Lifetime
- 1999-09-29 EP EP10176412.4A patent/EP2269602B1/en not_active Expired - Lifetime
- 1999-09-29 KR KR1020017003377A patent/KR101463243B1/ko not_active Expired - Lifetime
- 1999-09-29 ES ES10178657.2T patent/ES2519190T3/es not_active Expired - Lifetime
- 1999-09-29 DE DE69912972T patent/DE69912972T2/de not_active Revoked
- 1999-09-29 TR TR2007/04370T patent/TR200704370T2/xx unknown
- 1999-09-29 DE DE69943287T patent/DE69943287D1/de not_active Expired - Lifetime
- 1999-09-29 DK DK14176366.4T patent/DK2796138T3/en active
- 1999-09-29 PT PT141763664T patent/PT2796138T/pt unknown
- 1999-09-29 WO PCT/US1999/022622 patent/WO2000018386A2/en active Application Filing
- 1999-09-29 PT PT101764124T patent/PT2269602E/pt unknown
- 1999-09-29 CN CNB2004100973271A patent/CN100374114C/zh not_active Expired - Lifetime
- 1999-09-29 CA CA2774207A patent/CA2774207A1/en not_active Abandoned
- 1999-09-29 AT AT99956504T patent/ATE254458T1/de not_active IP Right Cessation
- 1999-09-29 DK DK10178657.2T patent/DK2301541T3/da active
- 1999-09-29 DK DK10176412.4T patent/DK2269602T3/en active
- 1999-09-29 PT PT101786572T patent/PT2301541E/pt unknown
- 1999-09-29 EP EP10178657.2A patent/EP2301541B1/en not_active Expired - Lifetime
- 1999-09-29 TR TR2001/00883T patent/TR200100883T2/xx unknown
- 1999-09-29 ES ES10176412.4T patent/ES2526521T3/es not_active Expired - Lifetime
- 1999-09-29 HK HK02100003.3A patent/HK1038691B/en not_active IP Right Cessation
- 1999-09-29 ES ES14176366.4T patent/ES2602956T3/es not_active Expired - Lifetime
- 1999-09-29 AU AU13101/00A patent/AU762827B2/en not_active Expired
- 1999-09-29 CA CA002659064A patent/CA2659064A1/en not_active Abandoned
- 1999-09-29 CN CNB998115096A patent/CN1184968C/zh not_active Ceased
- 1999-11-03 TW TW088116726A patent/TWI222361B/zh not_active IP Right Cessation
-
2008
- 2008-08-22 JP JP2008213954A patent/JP2009007375A/ja not_active Withdrawn
-
2011
- 2011-04-21 CY CY20111100409T patent/CY1111404T1/el unknown
- 2011-05-12 AR ARP110101646A patent/AR081393A2/es not_active Application Discontinuation
-
2012
- 2012-01-10 JP JP2012002159A patent/JP2012067141A/ja not_active Withdrawn
- 2012-11-02 JP JP2012242519A patent/JP5563041B2/ja not_active Expired - Lifetime
-
2014
- 2014-05-19 JP JP2014103658A patent/JP2014144982A/ja active Pending
- 2014-10-09 CY CY20141100819T patent/CY1115759T1/el unknown
-
2015
- 2015-01-09 CY CY20151100023T patent/CY1115916T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1111404T1 (el) | Αντιβιοτικες συνθεσεις οι οποιες πeριεχουν παραγωγα μοξιφλοξασινης για θεραπεια του οφθαλμου | |
| ES2167377T3 (es) | Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos. | |
| BR9914109A (pt) | Composições antibióticas para tratamento dos olhos, ouvidos e nariz | |
| TR200201505T2 (tr) | Terapötik maddeler olarak pirazolopirimidinler | |
| ES2186015T3 (es) | Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol. | |
| DE69429524D1 (de) | Aminocyclohexylester und ihre anwendung | |
| TR200101208T2 (tr) | Seçici COX-2 inhibitörleri olarak pirazolopiridin türevleri | |
| CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
| ES2170252T3 (es) | Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde. | |
| NO304884B1 (no) | 9-[(substituerte glycyl)amido]-6-demetyl-6-deoksotetracykliner, og medisinske preparater derav | |
| DE69724811D1 (de) | Pentafluorobenzensulfonamide und analoge | |
| FI970489L (fi) | Paikallisesti käytettäviä silmälääkekoostumuksia, jotka sisältävät doksepiinijohdoksia ja soveltuvat allergisten silmäsairauksien hoitoon | |
| RU95111308A (ru) | Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция | |
| BR9914128A (pt) | Composições antibióticas para tratamento do olho, ouvido e nariz | |
| BR9914158A (pt) | Composição antibiótica para o tratamento dos olhos, ouvidos e nariz | |
| NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
| CA2339384A1 (en) | Improved method for targeted topical treatment of disease | |
| EE9900450A (et) | Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine | |
| TR200103457T2 (tr) | 4-Fenil-Pirimidin Türevleri. | |
| ES2135722T3 (es) | 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina. | |
| PT1109560E (pt) | Compostos uteis como inidores de aicarft | |
| BR9805437A (pt) | Derivados de benzocicloalquenos heterocìclicos, processo para fabricação de derivados de benzocicloalquenos heterocìclicos e uso de derivados de benzocicloalquenos heterocìclicos. | |
| DK0773782T3 (da) | Terpenderivater (sarcodictyiner) anvendelse som antitumormidler | |
| ES2140672T3 (es) | Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos. | |
| UY26498A1 (es) | Pirroles sustituidos |